Navigation Links
Cloned receptor paves way for new breast and prostate cancer treatment
Date:9/13/2012

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study is being published this week in PNAS.

Genetically modified T cells (white blood corpuscles) have recently been shown to be extremely effective in treating certain forms of advanced cancer. T cells from the patient's own blood cells are isolated and equipped by genetic means with a new receptor that recognizes an antigen that is expressed in the tumour cells. These T cells are cultivated in a special clean room and then administered to the patient. Once inside the body, they seek out sub tumours and individual tumour cells and eliminate them.

This form of treatment attracted major attention in the world media last autumn when researchers at the University of Pennsylvania, Philadelphia, managed to cure two of three patients with an otherwise incurable form of leukaemia (Kalos et al., Sci Transl Med 3:95ra73, 2011; Porter et al., N Engl J Med 365:725-33, 2011). Trials with genetically modified T-cells have also met with some success in treating malignant melanoma at the National Cancer Institute in Bethesda (Morgan et al., Science 314:126-9, 2006).

Magnus Essand's research team at Uppsala University has now taken the first steps towards making this highly promising form of therapy feasible also for the major public health diseases prostate cancer and breast cancer.

"This is definitely a step along the way to a form of therapy also for our two largest cancer types (prostate cancer and breast cancer)."

Genetically modified T cells are one of two promising avenues the research team is pursuing in order to develop new treatments for cancer. It has taken nearly three years for the scientists to clone the T-ce
'/>"/>

Contact: Professor Magnus Essand
magnus.essand@igp.uu.se
46-018-611-0223
Uppsala University
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
3. Opioid receptors as a drug target for stopping obesity
4. H1N1 discovery paves way for universal flu vaccine: UBC research
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. Researchers develop a new cell and animal model of inflammatory breast cancer
7. Scientists uncover multiple faces of deadly breast cancer
8. Depo-Provera Birth Control Might Raise Breast Cancer Risk
9. Routine mammograms may result in significant overdiagnosis of invasive breast cancer
10. Mayo Clinic launches whole genome breast cancer study
11. Breast cancer patients suffer treatment-related side effects long after completing care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , ... July 03, 2015 , ... Renowned rhinoplasty ... dates for the 2016 Dallas Rhinoplasty Symposium . To be held from March ... meeting will be held at the Westin Galleria Dallas. , Designed to take participants ...
(Date:7/3/2015)... ... 03, 2015 , ... B. E. Smith, the only full-service ... a national chief nursing officer recruitment for Jane Phillips Medical Center ... industry, B. E. Smith has recently placed more than 1,000 healthcare executives into ...
(Date:7/3/2015)... ... 03, 2015 , ... Smoothies are all the rage right now and all ... quality ingredients. Aurora Natural is proud to introduce a new line of all natural ... antioxidants, vitamins and minerals! , Aurora is offering a variety of blends and stand-alone ...
(Date:7/3/2015)... Lewisville, TX (PRWEB) , ... July 03, 2015 , ... ... said First Choice Emergency Room , the largest network of independent freestanding emergency ... the new facility medical director of our Sienna Plantation facility,” said Executive Medical Director ...
(Date:7/3/2015)... ... , ... " Selfie on a Stick ” was featured on NewsWatch as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... memories. , Almost every smartphone has an incredibly powerful camera built into it. And ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2
... Congressman Chaka Fattah,(D- PA) responds to the ... "The numbers just don,t add up. This ... war, but he won,t support $35 million to ... health insurance is vital to their,well being. Today,s ...
... DIEGO, Oct. 3 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ... 2007 on Wednesday, October 10, 2007, at 11:45 a.m. ... The Palace Hotel in San,Francisco. Steve Worland, Ph.D., ... present an overview of Anadys and an update on,its ...
... Society of America (GSA) has received a five year, ... Foundation of New York, NY to provide financial and ... work and awards for 60 pre-dissertation doctoral students. This ... of over 46,000 geriatric social workers by supporting ...
... Insurance Companies Over Children, WASHINGTON, Oct. 3 ... that President Bush,s veto of the,Children,s Health Insurance ... about fixing the nation,s broken health care systems. ... Children,s Health,Insurance program for 6.6 million children and ...
... Ga., Oct. 3 Immucor, Inc. (Nasdaq:,BLUD), a ... blood transfusion industry, today reported financial results for ... Revenue for the fiscal first quarter was a ... the same period last year. Of the $12.6 ...
... LENEXA, Kan., Oct. 3 Mediware Information,Systems, Inc., ... 27, 2007, the,Nasdaq Stock Market notified the company ... which requires three,independent directors on the company,s audit ... of a director who served as an audit,committee ...
Cached Medicine News:Health News:Anadys Pharmaceuticals to Present at BIO InvestorForum 2007 2Health News:Hartford Foundation awards grant to address geriatric social work shortage 2Health News:Immucor Announces Record Fiscal First Quarter Revenues 2Health News:Immucor Announces Record Fiscal First Quarter Revenues 3Health News:Immucor Announces Record Fiscal First Quarter Revenues 4Health News:Immucor Announces Record Fiscal First Quarter Revenues 5Health News:Immucor Announces Record Fiscal First Quarter Revenues 6Health News:Immucor Announces Record Fiscal First Quarter Revenues 7Health News:Immucor Announces Record Fiscal First Quarter Revenues 8Health News:Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market 2
(Date:7/3/2015)... HUATULCO , Mexique, July 3, 2015 /PRNewswire/ ... médicale continue cible les épidémies que sont l,hypertension, ... latine, par l,intermédiaire de plateformes éducatives gratuites et ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... le diabète en ligne , Prendre en ...
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
(Date:7/2/2015)... , July 2, 2015  New product launches are ... leading role in educating thought leaders about new products, ... heavily influence how well a new therapy performs at ... from research and consulting leader Best Practices, LLC, critical ... to focus on are early stage thought leader (TL) ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... largest study comparing cancer risk of ezetimibe and ... March 25 A new study shows no ... combination treatments, compared to cancer rates of other ... by Tufts Medical Center lipid and health policy ...
... 25 Oramed Pharmaceuticals,Inc. (OTCBB: ORMP.OB) ( ... announced today that it has been selected ... "Open Label Study to Assess the Safety,Pharmacokinetics ... Formulations,in Subjects with Type 2 Diabetes (T2DM)" ...
Cached Medicine Technology:Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: